Innerer Wert von S&P & Nasdaq Kontaktieren

Perrigo Company plc PRGO NYSE

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • IE • USD

SharesGrow Score
41/100
1/7 Pass
SharesGrow Intrinsic Value
$20.94
+82.6%
Analyst Price Target
$21.50
+87.4%

Perrigo Company plc (PRGO) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Drug Manufacturers - Specialty & Generic Branche. Der Hauptsitz des Unternehmens ist in Dublin, Ireland. Der aktuelle CEO ist Patrick Lockwood-Taylor.

PRGO hat IPO-Datum 1991-12-17, 8,379 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $1.58B.

Über Perrigo Company plc

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

📍 The Sharp Building, Dublin 2 📞 353 1 709 4000
Unternehmensdetails
SektorGesundheitswesen
BrancheDrug Manufacturers - Specialty & Generic
LandIreland
BörseNYSE
WährungUSD
IPO-Datum1991-12-17
CEOPatrick Lockwood-Taylor
Mitarbeiter8,379
Handelsinformationen
Aktueller Kurs$11.47
Marktkapitalisierung$1.58B
52-Wochen-Spanne9.23-28.44
Beta0.49
ETFNein
ADRNein
CUSIPG97822103
Kontaktieren
🎓
SharesGrow Akademie
Lernen Sie inneren Wert zu berechnen und unterbewertete Aktien zu finden.
Wöchentliche Live-Sessions
Nachricht senden